Masimo | MASI - Net Income


Masimo reported $-100.4M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Align Technology USD 56.75M 67.86M Sep/2025
AtriCure USD -267K 5.92M Sep/2025
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Boston Scientific USD 755M 42M Sep/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
General Electric Aerospace USD 2.54B 384M Dec/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Haemonetics USD 38.68M 4.65M Sep/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Owens Minor USD -24.98M 271.13M Mar/2025
ResMed USD 392.59M 44.06M Dec/2025
Steris USD 191.9M 14.5M Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025